Detalhe da pesquisa
1.
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations.
Proc Natl Acad Sci U S A
; 116(20): 10025-10030, 2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043566
2.
Functional dissection of the KRAS G12C mutation by comparison among multiple oncogenic driver mutations in a lung cancer cell line model.
Biochem Biophys Res Commun
; 534: 1-7, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33302159
3.
Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.
BMJ Open Respir Res
; 11(1)2024 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395459
4.
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Nat Genet
; 56(1): 60-73, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049664
5.
Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancer.
J Clin Invest
; 132(4)2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166243
6.
SHOC2 Is a Critical Modulator of Sensitivity to EGFR-TKIs in Non-Small Cell Lung Cancer Cells.
Mol Cancer Res
; 19(2): 317-328, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106373
7.
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.
Cancer Res
; 81(14): 3916-3929, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083250
8.
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.
BMJ Open Respir Res
; 8(1)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34836924
9.
IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer.
Mol Cancer Res
; 18(4): 549-559, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941753
10.
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948652
11.
Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations.
Lung Cancer
; 127: 146-152, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642543
12.
Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab.
Mol Cancer Ther
; 18(9): 1593-1601, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253648
13.
Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer.
Onco Targets Ther
; 11: 3335-3343, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29922072
14.
Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
Bioorg Med Chem Lett
; 16(11): 2986-90, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16540315